首页> 外文期刊>海南医科大学学报(英文版) >Influence of probucol-assisted retinal photocoagulation therapy on the visual performance and serum biochemical indexes in patients with early proliferative diabetic retinopathy
【24h】

Influence of probucol-assisted retinal photocoagulation therapy on the visual performance and serum biochemical indexes in patients with early proliferative diabetic retinopathy

机译:普罗布考辅助视网膜光凝治疗对早期增生性糖尿病视网膜病变患者视力和血清生化指标的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: To explore the influence of probucol-assisted retinal photocoagulation therapy on the visual performance and serum biochemical indexes in patients with early proliferative diabetic retinopathy. Methods: A total of 170 patients with early proliferative DR who were treated in the hospital between December 2014 and May 2017 were retrospectively analyzed and divided into the control group (n=107) who received retinal photocoagulation therapy alone and the probucol group (n=63) who received probucol-assisted retinal photocoagulation therapy. The differences in the contents of visual performance indexes as well as serum angiogenesis indexes, inflammatory mediators and oxidative stress indexes were compared between the two groups before treatment and after 6 weeks of treatment. Results: Before treatment, the differences in the levels of visual performance indexes as well as serum contents of angiogenesis indexes, inflammatory mediators and oxidative stress indexes were not statistically significant between the two groups of patients. After 6 weeks of treatment, mean vision, 30 visual acuity and 30-60 visual acuity of probucol group were higher than those of control group; serum angiogenesis indexes HIF-1, VEGF and Ang-2 contents were lower than those of control group; serum inflammatory mediators ICAM-1, IL-2, IL-23 and TNF-α contents were lower than those of control group; serum oxidative stress index MDA content was lower than that of control group whereas TAC content was higher than that of control group. Conclusion: Probucol-assisted retinal photocoagulation therapy can effectively optimize the visual performance and promote the homeostasis recovery in patients with early proliferative diabetic retinopathy.
机译:目的:探讨普罗布考辅助视网膜光凝治疗对早期增生性糖尿病性视网膜病患者的视觉性能和血清生化指标的影响。方法:回顾性分析2014年12月至2017年5月期间在医院接受治疗的170例早期增生性DR患者,将其分为仅接受视网膜光凝治疗的对照组(n = 107)和普罗布考组(n = 63)接受普罗布考辅助的视网膜光凝治疗。比较两组治疗前和治疗6周后视觉性能指标,血清血管生成指标,炎性介质和氧化应激指标的差异。结果:在治疗前,两组患者的视觉性能指标水平,血管生成指标,炎性介质和氧化应激指标的血清含量差异无统计学意义。治疗6周后,普罗布考组的平均视力,30视力和30-60视力均高于对照组。血清血管生成指数HIF-1,VEGF和Ang-2含量低于对照组。血清炎症介质ICAM-1,IL-2,IL-23和TNF-α含量低于对照组。血清氧化应激指标MDA含量低于对照组,而TAC含量高于对照组。结论:普罗布考辅助的视网膜光凝治疗可有效优化早期增生性糖尿病性视网膜病患者的视觉性能,并促进其稳态恢复。

著录项

  • 来源
    《海南医科大学学报(英文版)》 |2017年第23期|140-144|共5页
  • 作者单位

    Ophthalmology Department, the People's Hospital of Kaizhou District Chongqing, Kaizhou District, Chongqing, 405400;

    Ophthalmology Department, the People's Hospital of Kaizhou District Chongqing, Kaizhou District, Chongqing, 405400;

    Ophthalmology Department, the People's Hospital of Kaizhou District Chongqing, Kaizhou District, Chongqing, 405400;

    Ophthalmology Department, the People's Hospital of Kaizhou District Chongqing, Kaizhou District, Chongqing, 405400;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号